[Response to the administration of corticosteroids in patients with chronic obstructive lung disease and asthma]

Autor: Jv, Barbas Filho, Cs, Barbas, Cr, Carvalho, Godoy R, Vianna Edos S, Lorenzi Filho G

Publikováno v: Europe PubMed Central

A spirometric study was performed in order to evaluate the response to the administration of 200 mg of salbutamol, just before and after the daily administration of 8 mg of triamcinolone, for an average period of 2 weeks, in 21 patients with chronic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9b2ec117b0c9b8f3511bcea63b397895
https://pubmed.ncbi.nlm.nih.gov/1843711

Dyspnea descriptors developed in Brazil: application in obese patients and in patients with cardiorespiratory diseases.

Autor: Teixeira CA; Department of Clinical Medicine, University of São Paulo at Ribeirão Preto School of Medicine – Ribeirão Preto, Brazil., Rodrigues Júnior AL, Straccia LC, Vianna Edos S, Silva GA, Martinez JA

Publikováno v: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia [J Bras Pneumol] 2011 Jul-Aug; Vol. 37 (4), pp. 446-54.

[Kidney failure as a complication of the treatment of pulmonary paracoccidioidomycosis].

Autor: Fiks IN; Disciplina de Pneumologia, Faculdade de Medicina, Universidade de São Paulo., Follador CR, Barbas Filho JV, Kairalla RA, Oliveira-Vianna Edos S, Stávale ML, de Carvalho CR

Publikováno v: Revista do Hospital das Clinicas [Rev Hosp Clin Fac Med Sao Paulo] 1992 Mar-Apr; Vol. 47 (2), pp. 103-5.

[Response to the administration of corticosteroids in patients with chronic obstructive lung disease and asthma].

Autor: Barbas Filho JV; Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo., Barbas CS, de Carvalho CR, Godoy R, Vianna Edos S, Lorenzi Filho G

Publikováno v: Revista do Hospital das Clinicas [Rev Hosp Clin Fac Med Sao Paulo] 1991 Jul-Aug; Vol. 46 (4), pp. 159-62.

Antipsychotics and Risk of Acute Respiratory Failure in U.S. Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.

Autor: Perez-Vilar S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. silvia.perezvilar@fda.hhs.gov., Mosholder AD; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Smith ER; Acumen LLC, Burlingame, CA, USA., Lee HS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Lo AC; Acumen LLC, Burlingame, CA, USA., Stone M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Brehm A; Acumen LLC, Burlingame, CA, USA., Zhao Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Avagyan A; Acumen LLC, Burlingame, CA, USA., Leishear K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Wernecke M; Acumen LLC, Burlingame, CA, USA., MaCurdy TE; Acumen LLC, Burlingame, CA, USA.; Department of Economics, Stanford University, Stanford, CA, USA., Kelman JA; Centers for Medicare & Medicaid Services, Washington, DC, USA., Graham DJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.